CTS OpTmizer One SFM Offers Enhanced T Cell Expansion and High Viability While Maintaining Early Memory Cell Phenotype

This application note evaluates CTS™ OpTmizer™ One SFM, an animal origin–free, single-part medium, for its performance in expanding healthy and diseased donor T cells. It consistently outperforms or matches competing AOF and xeno-free media across key parameters such as expansion, viability, and early memory phenotype maintenance. The medium also demonstrates strong results in lentiviral transduction efficiency, making it ideal for both research and clinical manufacturing workflows.

Learn how CTS OpTmizer One SFM can boost your T cell therapy results.

First Name *

Last Name *

Company Email *

Business Phone *

Company Name *

Job Title *

Street Address *

City *

State

Zip/Postcode *

Country *

The Medicine Maker would like to contact you in the future on their products and services via phone, email, and/or post. For more details on our information practices and how to unsubscribe, please see their Privacy Policy. You can unsubscribe at any time.

Would you like a Thermo Fisher Scientific technical specialist to contact you? *

Would you like to eceive email updates from The Medicine Maker products, services and events? *

For full details of how Thermo will treat your information please click here to view Thermo's privacy policy.

Click here to view our privacy policy regarding how The Medicine Maker will store your information.

Please agree to the conditions

You have been directed to this site by Demand Papers. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.